|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 395.4 INR | -0.24% |
|
+1.54% | -14.66% |
| Mar. 19 | IOL Chemicals Gets Zero Observations from Brazilian Health Regulatory Agency After Inspection of Units | MT |
| Feb. 19 | IOL Chemicals Gets Nod to Export Diabetes Drug to China | MT |
IOL Chemicals and Pharmaceuticals Limited reported earnings results for the fourth quarter ended March 31, 2023. For the fourth quarter, the company reported sales was INR 5,872.1 million compared to INR 5,724.9 million a year ago. Revenue was INR 5,959.4 million compared to INR 5,794.2 million a year ago.
Net income was INR 647.8 million compared to INR 297.6 million a year ago. Basic earnings per share from continuing operations was INR 11.03 compared to INR 5.07 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -14.66% | 279M | |
| +34.00% | 664B | |
| +29.29% | 567B | |
| -7.75% | 354B | |
| +18.53% | 330B | |
| +4.95% | 286B | |
| +13.79% | 234B | |
| +4.93% | 199B | |
| -9.78% | 196B | |
| -4.89% | 148B |
IOL CHEMICALS AND PHARMACEUTICALS LIMITED 
